ArticleJournal of neuroinflammation2019

Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity.

Martina Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.